Identification and evaluation of neutral sphingomyelinase 2 inhibitors

Archives of Pharmacal Research

Volumn 34, Issue 2, 2011, Pages 229-236

  Lee, Dong Hun ^a   Kim, Sung Hyun ^a   Ahn, Kyong Hoon ^a   Kim, Seok Kyun ^a   Choi, Jong Min ^a   Ji, Jung Eun ^a   Won, Jong Hoon ^a   Park, Yang Hui ^a   Lim, Chaemin ^b   Kim, Sanghee ^b   Kim, Dae Kyong ^a  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Inhibitors; Signal transduction; Sphingolipids; Sphingomyelinase

Indexed keywords

D ARABINO PHYTOSPHINGOSINE; D LYXOLYXOPHYTOSPHINGOSINE; ENZYME INHIBITOR; GW 4869; MAGNESIUM ION; NEUTRAL SPHINGOMYELINASE 2; PHOSPHODIESTERASE; PHYTOSPHINGOSINE; SPHINGOMYELIN PHOSPHODIESTERASE INHIBITOR; TRITON X 100; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG IDENTIFICATION; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN;

ANILINE COMPOUNDS; ANIMALS; BENZYLIDENE COMPOUNDS; CATTLE; CERAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; HEK293 CELLS; HUMANS; MAGNESIUM; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOMYELINS; SPHINGOSINE;

EID: 79953329227     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-011-0208-y     Document Type: Article

References (42)

1. Bose, R., Verheij, M., Haimovitz-Friedman, A., Scotto, K., Fuks, Z., and Kolesnick, R., Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell, 82, 405-414 (1995).
2. Carre, J. B., Morand, O., Homayoun, P., Roux, F., Bourre, J. M., and Baumann, N., Purified rat brain microvessels exhibit both acid and neutral sphingomyelinase activities. J. Neurochem., 52, 1294-1299 (1989).
3. Casaccia-Bonnefil, P., Aibel, L., and Chao, M. V., Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death. J. Neurosci. Res., 43, 382-389 (1996).
4. Chakraborty, G., Ziemba, S., Drivas, A., and Ledeen, R. W., Myelin contains neutral sphingomyelinase activity that is stimulated by tumor necrosis factor-alpha. J. Neurosci. Res., 50, 466-476 (1997).
5. Chatterjee, S. and Ghosh, N., Neutral sphingomyelinase from human urine. Purification and preparation of mono-specific antibodies. J. Biol. Chem., 264, 12554-12561 (1989).
6. Dobrowsky, R. T., Jenkins, G. M., and Hannun, Y. A., Neurotrophins induce sphingomyelin hydrolysis. Modulation by co-expression of p75NTR with Trk receptors. J. Biol. Chem., 270, 22135-22142 (1995).
7. Fiebich, B. L., Lieb, K., Berger, M., and Bauer, J., Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells. J. Neuroimmunol., 63, 207-211 (1995).
8. Funakoshi, T., Yasuda, S., Fukasawa, M., Nishijima, M., and Hanada, K., Reconstitution of ATP- and cytosol-dependent transport of de novo synthesized ceramide to the site of sphingomyelin synthesis in semi-intact cells. J. Biol. Chem., 275, 29938-29945 (2000).
9. Hannun, Y. A., The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem., 269, 3125-3128 (1994).
10. Hofmann, K., Tomiuk, S., Wolff, G., and Stoffel, W., Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc. Natl. Acad. Sci. U. S. A., 97, 5895-5900 (2000).
11. Hunot, S., Brugg, B., Ricard, D., Michel, P. P., Muriel, M. P., Ruberg, M., Faucheux, B. A., Agid, Y., and Hirsch, E. C., Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc. Natl. Acad. Sci. U. S. A., 94, 7531-7536 (1997).
12. Ito, H., Murakami, M., Furuhata, A., Gao, S., Yoshida, K., Sobue, S., Hagiwara, K., Takagi, A., Kojima, T., Suzuki, M., Banno, Y., Tanaka, K., Tamiya-Koizumi, K., Kyogashima, M., Nozawa, Y., and Murate, T., Transcriptional regulation of neutral sphingomyelinase 2 gene expression of a human breast cancer cell line, MCF-7, induced by the anticancer drug, daunorubicin. Biochim. Biophys. Acta, 1789, 681-690 (2009).
13. Jayadev, S., Liu, B., Bielawska, A. E., Lee, J. Y., Nazaire, F., Pushkareva, M., Obeid, L. M., and Hannun, Y. A., Role for ceramide in cell cycle arrest. J. Biol. Chem., 270, 2047-2052 (1995).
14. Kalen, A., Borchardt, R. A., and Bell, R. M., Elevated ceramide levels in GH4C1 cells treated with retinoic acid. Biochim. Biophys. Acta, 1125, 90-96 (1992).
15. Kim, S. K., Ahn, K. H., Jeon, H. J., Lee, D. H., Jung, S. Y., Jung, K. M., and Kim, D. K., Purification of neutral sphingomyelinase 2 from bovine brain and its calcium-dependent activation. J. Neurochem., 112, 1088-1097 (2010).
16. Kroesen, B. J., Pettus, B., Luberto, C., Busman, M., Sietsma, H., De Leij, L., and Hannun, Y. A., Induction of apoptosis through B-cell receptor cross-linking occurs via de novo generated C16-ceramide and involves mitochondria. J. Biol. Chem., 276, 13606-13614 (2001).
17. Krut, O., Wiegmann, K., Kashkar, H., Yazdanpanah, B., and Kronke, M., Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein. J. Biol. Chem., 281, 13784-13793 (2006).
18. Kubota, M., Kitahara, S., Shimasaki, H., and Ueta, N., Accumulation of ceramide in ischemic human brain of an acute case of cerebral occlusion. Jpn. J. Exp. Med., 59, 59-64 (1989).
19. Lee, J. S., Min, D. S., Park, C., Park, C. S., and Cho, N. J., Phytosphingosine and C2-phytoceramide induce cell death and inhibit carbachol-stimulated phospholipase D activation in Chinese hamster ovary cells expressing the Caenorhabditis elegans muscarinic acetylcholine receptor. FEBS Lett., 499, 82-86 (2001).
20. Lee, J. T., Xu, J., Lee, J. M., Ku, G., Han, X., Yang, D. I., Chen, S., and Hsu, C. Y., Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol., 164, 123-131 (2004).
21. Liu, B., Hassler, D. F., Smith, G. K., Weaver, K., and Hannun, Y. A., Purification and characterization of a membrane bound neutral pH optimum magnesium-dependent and phosphatidylserine-stimulated sphingomyelinase from rat brain. J. Biol. Chem., 273, 34472-34479 (1998).
22. Luberto, C., Hassler, D. F., Signorelli, P., Okamoto, Y., Sawai, H., Boros, E., Hazen-Martin, D. J., Obeid, L. M., Hannun, Y. A., and Smith, G. K., Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J. Biol. Chem., 277, 41128-41139 (2002).
23. Macphee, I. J. and Barker, P. A., Brain-derived neurotrophic factor binding to the p75 neurotrophin receptor reduces TrkA signaling while increasing serine phosphorylation in the TrkA intracellular domain. J. Biol. Chem., 272, 23547-23551 (1997).
24. Magen, D., Georgopoulos, C., Bross, P., Ang, D., Segev, Y., Goldsher, D., Nemirovski, A., Shahar, E., Ravid, S., Luder, A., Heno, B., Gershoni-Baruch, R., Skorecki, K., and Mandel, H., Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am. J. Hum. Genet, 83, 30-42 (2008).
25. Milhas, D., Clarke, C. J., and Hannun, Y. A., Sphingomyelin metabolism at the plasma membrane: implications for bioactive sphingolipids. FEBS Lett., 584, 1887-1894 (2010).
26. Nara, F., Tanaka, M., Masuda-Inoue, S., Yamasato, Y., Doi-Yoshioka, H., Suzuki-Konagai, K., Kumakura, S., and Ogita, T., Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima. J. Antibiot. (Tokyo), 52, 531-535 (1999).
27. Obeid, L. M., Linardic, C. M., Karolak, L. A., and Hannun, Y. A., Programmed cell death induced by ceramide. Science, 259, 1769-1771 (1993).
28. Okazaki, T., Bell, R. M., and Hannun, Y. A., Sphingomyelin turnover induced by vitamin D3 in HL-60 cells. Role in cell differentiation. J. Biol. Chem., 264, 19076-19080 (1989).
29. Okazaki, T., Bielawska, A., Bell, R. M., and Hannun, Y. A., Role of ceramide as a lipid mediator of 1 alpha,25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem., 265, 15823-15831 (1990).
30. Perry, D. K., Carton, J., Shah, A. K., Meredith, F., Uhlinger, D. J., and Hannun, Y. A., Serine palmitoyltransferase regulates de novo ceramide generation during etoposide-induced apoptosis. J. Biol. Chem., 275, 9078-9084 (2000).
31. Riley, R. T., Enongene, E., Voss, K. A., Norred, W. P., Meredith, F. I., Sharma, R. P., Spitsbergen, J., Williams, D. E., Carlson, D. B., and Merrill, A. H., Jr., Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Environ. Health Perspect., 109 Suppl 2, 301-308 (2001).
32. Sawai, H., Domae, N., Nagan, N., and Hannun, Y. A., Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J. Biol. Chem., 274, 38131-38139 (1999).
33. Spiegel, S. and Merrill, A. H., Jr., Sphingolipid metabolism and cell growth regulation. FASEB J., 10, 1388-1397 (1996).
34. Stoffel, A. and Levine, A. J., Actvation of NF-kappaB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis: a directional link between NF-kappaB and p53. Cell Cycle, 3, 1017-1020 (2004).
35. Stoffel, W., Jenke, B., Holz, B., Binczek, E., Gunter, R. H., Knifka, J., Koebke, J., and Niehoff, A., Neutral sphingomyelinase (SMPD3) deficiency causes a novel form of chondrodysplasia and dwarfism that is rescued by Col2A1-driven smpd3 transgene expression. Am. J. Pathol., 171, 153-161 (2007).
36. Tomiuk, S., Hofmann, K., Nix, M., Zumbansen, M., and Stoffel, W., Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl. Acad. Sci. U. S. A., 95, 3638-3643 (1998).
37. Tomiuk, S., Zumbansen, M., and Stoffel, W., Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J. Biol. Chem., 275, 5710-5717 (2000).
38. Venable, M. E., Lee, J. Y., Smyth, M. J., Bielawska, A., and Obeid, L. M., Role of ceramide in cellular senescence. J. Biol. Chem., 270, 30701-30708 (1995).
39. Xu, Y., Bialik, S., Jones, B. E., Iimuro, Y., Kitsis, R. N., Srinivasan, A., Brenner, D. A., and Czaja, M. J., NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am. J. Physiol., 275, C1058-C1066 (1998).
40. Yamaguchi, S. and Suzuki, K., Purification and characterization of sphingomyelinase from human brain. J. Biol. Chem., 252, 3805-3813 (1977).
41. Yoo, H. H., Son, J., and Kim, D. H., Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 843, 327-333 (2006).
42. Yoshimura, S., Banno, Y., Nakashima, S., Takenaka, K., Sakai, H., Nishimura, Y., Sakai, N., Shimizu, S., Eguchi, Y., Tsujimoto, Y., and Nozawa, Y., Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death. Inhibitory effects of Bcl-2 on ceramide formation and caspase-3 activation. J. Biol. Chem., 273, 6921-6927 (1998).